Our findings that TNFSF15 facilitates the differentiation of bone marrow-derived CD11b+ cells to vascular pericytes not only yield new insights into the molecular mechanisms underlying neovascularization but also provide a potentially feasible approach to modifying the tumor microenvironment to increase the efficacy of cancer therapies. The gene discussed is ITGAM; the disease is neoplasm.